Less-aggressive surgical management and long-term outcomes of jugular foramen paragangliomas: a neurosurgical perspective

医学 颈静脉孔 外科 神经血管束 吞咽 病变 颅骨
作者
Da Li,Xiao‐Jun Zeng,Shuyu Hao,Liang Wang,Jie Tang,Xinru Xiao,Guolu Meng,Guijun Jia,Liwei Zhang,Zhen Wu,Junting Zhang
出处
期刊:Journal of Neurosurgery [American Association of Neurological Surgeons]
卷期号:125 (5): 1143-1154 被引量:23
标识
DOI:10.3171/2015.10.jns151875
摘要

OBJECTIVE The aim of this study was to analyze the neurological functional outcome and recurrent risks in surgically treated jugular foramen paragangliomas (JFPs) and to propose an individualized therapeutic strategy. METHODS Clinical charts and radiological information were reviewed retrospectively in 51 consecutive cases of JFPs. Less-aggressive surgical interventions were adopted with the goal of preserving neurovascular structures. Scheduled follow-up was performed. RESULTS The mean age of the patients in the cases reviewed was 41.6 years, and the group included 27 females (52.9%). The mean preoperative Karnofsky Performance Scale (KPS) score was 78.4. The mean lesion size was 3.8 cm. Forty-three cases (84.3%) were Fisch Type D, including 37 cases (72.5%) of Type Di1 and Di2. Thirty-seven cases (72.5%) were Glasscock-Jackson Type III–IV. Gross-total resection and subtotal resection were achieved in 26 (51.0%) and 22 (43.1%) cases, respectively. Surgical morbidities occurred in 23 patients (45.1%), without surgery-related mortality after the first operation. The mean postoperative KPS scores at discharge, 3 months, 1 year, and most recent evaluation were 71.8, 77.2, 83.2, and 79.6, respectively. The mean follow-up duration was 85.7 months. The tumor recurrence/regrowth (R/R) rate was 11.8%. Compared with preoperative status, swallowing function improved or stabilized in 96.1% and facial function improved or stabilized in 94.1% of patients. A House-Brackmann scale Grade I/II was achieved in 43 patients (84.3%). Overall neurological status improved or stabilized in 90.0% of patients. Pathological mitosis (HR 10.640, p = 0.009) was the most significant risk for tumor R/R. A 1-year increase in age (OR 1.115, p = 0.037) and preoperative KPS score < 80 (OR 11.071, p = 0.018) indicated a risk for recent poor neurological function (KPS < 80). Overall R/R-free survival, symptom progression–free survival, and overall survival at 15 years were 78.9%, 86.8%, and 80.6%, respectively. CONCLUSIONS Surgical outcomes for JFPs were acceptable using a less-aggressive surgical strategy. Most patients could adapt to surgical morbidities and carry out normal life activities. Preserving neurological function was a priority, and maximal decompression with or without radiotherapy was desirable to preserve a patient's quality of life when radical resection was not warranted. Early surgery plus preoperative devascularization was proposed, and radiotherapy was mandatory for lesions with pathological mitosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
郝郝完成签到,获得积分10
1秒前
上官若男的应助被淡然新竹采纳,获得10
1秒前
zhuo发布了新的文献求助10
2秒前
2秒前
2秒前
小鱼干发布了新的文献求助10
2秒前
wen完成签到,获得积分10
2秒前
村上种树发布了新的文献求助10
2秒前
酷炫雁荷发布了新的文献求助10
3秒前
Vivi关注了科研通微信公众号
3秒前
3秒前
3秒前
3秒前
4秒前
在水一方的应助被i7采纳,获得10
4秒前
4秒前
gc完成签到,获得积分20
4秒前
怀挺啊完成签到,获得积分10
5秒前
5秒前
pyimh发布了新的文献求助10
5秒前
孝顺的猫完成签到,获得积分10
5秒前
Jun举报Sun的求助涉嫌违规
5秒前
dis完成签到,获得积分10
5秒前
5秒前
拔土豆的草完成签到,获得积分10
6秒前
满意若烟完成签到,获得积分10
6秒前
虎福完成签到,获得积分10
6秒前
koala完成签到,获得积分10
7秒前
搞怪汉堡发布了新的文献求助10
7秒前
7秒前
7秒前
7秒前
chuyangyang发布了新的文献求助10
8秒前
Orange的应助被愤怒的笑天采纳,获得10
8秒前
8秒前
xiepeijuan的应助被百里新梅采纳,获得10
8秒前
清脆水之发布了新的文献求助20
8秒前
苹果发布了新的文献求助10
9秒前
未du完成签到,获得积分10
9秒前
黑犬发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170021
求助须知:如何正确求助?哪些是违规求助? 9563040
关于积分的说明 21768210
捐赠科研通 7761506
什么是DOI,文献DOI怎么找? 3430553
关于科研通互助平台的介绍 2554373
邀请新用户注册赠送积分活动 2475269